Thrivent Financial for Lutherans’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91M | Sell |
20,491
-810
| -4% | -$71.7K | ﹤0.01% | 1499 |
|
|
2025
Q4 | $1.71M | Sell |
21,301
-1,366
| -6% | -$114K | ﹤0.01% | 1583 |
|
|
2025
Q3 | $2.21M | Sell |
22,667
-959
| -4% | -$77.2K | ﹤0.01% | 1279 |
|
|
2025
Q2 | $1.65M | Sell |
23,626
-3,747
| -14% | -$214K | ﹤0.01% | 1483 |
|
|
2025
Q1 | $1.48M | Sell |
27,373
-1,250
| -4% | -$79K | ﹤0.01% | 1453 |
|
|
2024
Q4 | $2.05M | Buy |
28,623
+383
| +1% | +$31.8K | ﹤0.01% | 1416 |
|
|
2024
Q3 | $2.96M | Sell |
28,240
-1,119
| -4% | -$131K | 0.01% | 1194 |
|
|
2024
Q2 | $4.17M | Buy |
29,359
+1,004
| +4% | +$116K | 0.01% | 968 |
|
|
2024
Q1 | $3.16M | Sell |
28,355
-2,454
| -8% | -$292K | 0.01% | 1101 |
|
|
2023
Q4 | $4M | Buy |
30,809
+788
| +3% | +$109K | 0.01% | 958 |
|
|
2023
Q3 | $4.89M | Sell |
30,021
-1,271
| -4% | -$224K | 0.01% | 816 |
|
|
2023
Q2 | $5.74M | Sell |
31,292
-1,188
| -4% | -$171K | 0.01% | 804 |
|
|
2023
Q1 | $4.33M | Sell |
32,480
-1,215
| -4% | -$143K | 0.01% | 861 |
|
|
2022
Q4 | $2.67M | Sell |
33,695
-453
| -1% | -$31.9K | 0.01% | 1076 |
|
|
2022
Q3 | $2.07M | Sell |
34,148
-166,504
| -83% | -$10.8M | 0.01% | 1196 |
|
|
2022
Q2 | $11M | Sell |
200,652
-52,466
| -21% | -$3.04M | 0.03% | 575 |
|
|
2022
Q1 | $19.1M | Sell |
253,118
-318,919
| -56% | -$21.8M | 0.04% | 478 |
|
|
2021
Q4 | $42.7M | Sell |
572,037
-29
| -0% | -$1.72K | 0.08% | 279 |
|
|
2021
Q3 | $26.9M | Sell |
572,066
-12,400
| -2% | -$539K | 0.05% | 375 |
|
|
2021
Q2 | $23.6M | Buy |
584,466
+24,389
| +4% | +$1.01M | 0.05% | 410 |
|
|
2021
Q1 | $23M | Buy |
560,077
+532,328
| +1,918% | +$19.9M | 0.05% | 405 |
|
|
2020
Q4 | $808K | Hold |
27,749
| – | – | ﹤0.01% | 1896 |
|
|
2020
Q3 | $610K | Buy |
27,749
+232
| +0.8% | +$5.92K | ﹤0.01% | 1867 |
|
|
2020
Q2 | $766K | Buy |
27,517
+345
| +1% | +$8.41K | ﹤0.01% | 1678 |
|
|
2020
Q1 | $498K | Buy |
27,172
+1,357
| +5% | +$31.5K | ﹤0.01% | 1702 |
|
|
2019
Q4 | $622K | Buy |
25,815
+126
| +0.5% | +$2.65K | ﹤0.01% | 1777 |
|
|
2019
Q3 | $439K | Buy |
25,689
+146
| +0.6% | +$2.33K | ﹤0.01% | 1904 |
|
|
2019
Q2 | $384K | Buy |
25,543
+783
| +3% | +$14K | ﹤0.01% | 1947 |
|
|
2019
Q1 | $498K | Buy |
24,760
+1,813
| +8% | +$36.8K | ﹤0.01% | 1806 |
|
|
2018
Q4 | $408K | Buy |
22,947
+504
| +2% | +$8.96K | ﹤0.01% | 1691 |
|
|
2018
Q3 | $441K | Buy |
22,443
+391
| +2% | +$8.06K | ﹤0.01% | 1742 |
|
|
2018
Q2 | $437K | Buy |
22,052
+1,709
| +8% | +$37.6K | ﹤0.01% | 1748 |
|
|
2018
Q1 | $500K | Buy |
20,343
+991
| +5% | +$26K | ﹤0.01% | 1642 |
|
|
2017
Q4 | $555K | Buy |
19,352
+18,363
| +1,857% | +$578K | ﹤0.01% | 1620 |
|
|
2017
Q3 | $27K | Buy |
+989
| New | +$21.9K | ﹤0.01% | 2046 |
|
Other funds holding ACLS
VPM
RP
VCM
Thrivent Financial for Lutherans's ACLS Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Axcelis (ACLS) stake by 3.8% in Q1 2026, selling an estimated $71.7K and leaving 20,491 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.
Thrivent Financial for Lutherans first reported a position in ACLS in Q3 2017 and has held it in 35 quarters since. The position peaked at $42.7M in Q4 2021. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Thrivent Financial for Lutherans held 20,491 shares of Axcelis worth $1.91M as of Q1 2026.
- Thrivent Financial for Lutherans sold 810 Axcelis shares in Q1 2026, an estimated $71.7K.
- Axcelis made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1499 holding.
- Thrivent Financial for Lutherans first reported a position in Axcelis in Q3 2017 and has held it in 35 quarters since.
- Thrivent Financial for Lutherans's Axcelis position peaked at $42.7M in Q4 2021.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.